Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-25

FDA Approved: KIMMTRAK — Original Application (Immunocore Commercial LLC)

View source ↗

Summary

FDA approved KIMMTRAK (tebentafusp) in an original application for adults with unresectable or metastatic uveal melanoma, marking the first approval for this th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KIMMTRAK (tebentafusp)

Snippet

ORIG AP for KIMMTRAK (TEBENTAFUSP)